Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene
暂无分享,去创建一个
Anna C. Salzberg | S. Amin | T. Cooper | K. El-Bayoumy | C. Aliaga | Junjia Zhu | Kun-Ming Chen | Yuan-Wan Sun | K. Gowda | Y. Imamura Kawasawa | Carla R. Caruso
[1] S. Amin,et al. Carcinogenesis of the Oral Cavity: Environmental Causes and Potential Prevention by Black Raspberry. , 2017, Chemical research in toxicology.
[2] S. Tomida,et al. Significance of FGF9 gene in resistance to anti‐EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti‐EGFR therapies , 2017, Molecular carcinogenesis.
[3] Edward S. Kim,et al. New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development , 2015, Cancer Prevention Research.
[4] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[5] L. Kowalski,et al. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma , 2015, Clinical & Experimental Metastasis.
[6] Guang-xun Li,et al. NNK-Induced DNA Methyltransferase 1 in Lung Tumorigenesis in A/J Mice and Inhibitory Effects of (−)-Epigallocatechin-3-Gallate , 2015, Nutrition and cancer.
[7] E. Mendonça,et al. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study , 2014, BMC Cancer.
[8] Sigrid A. Langhans,et al. Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition , 2014, Front. Oncol..
[9] A. Besaratinia,et al. Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis. , 2014, Carcinogenesis.
[10] S. Amin,et al. Simultaneous Detection of Deoxyadenosine and Deoxyguanosine Adducts in the Tongue and Other Oral Tissues of Mice Treated with Dibenzo[a,l]pyrene , 2014, Chemical research in toxicology.
[11] Samy Lamouille,et al. Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.
[12] S. Cheong,et al. Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory , 2014, International journal of cancer.
[13] Wendy P Robinson,et al. Global analysis of DNA methylation changes during progression of oral cancer. , 2013, Oral oncology.
[14] K. Ahn,et al. Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: An environmental pollutant and a tobacco smoke constituent , 2013, International journal of cancer.
[15] D. Luce,et al. A review of risk factors for oral cavity cancer: the importance of a standardized case definition. , 2013, Community dentistry and oral epidemiology.
[16] Francine E. Garrett-Bakelman,et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles , 2012, Genome Biology.
[17] S. Yonezawa,et al. Aberrant DNA methylation of tumor‐related genes in oral rinse , 2012, Cancer.
[18] K. Ahn,et al. Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: a potential new model for oral cancer , 2012, International journal of cancer.
[19] Francine E. Garrett-Bakelman,et al. Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia , 2012, PLoS genetics.
[20] C. Garnis,et al. Methylation-Mediated Molecular Dysregulation in Clinical Oral Malignancy , 2012, Journal of oncology.
[21] M. Worsham,et al. Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer , 2012, Journal of oncology.
[22] K. Ogbureke,et al. Overview of Oral Cancer , 2012 .
[23] S. Amin,et al. Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS. , 2011, Chemical research in toxicology.
[24] N. Dalay,et al. Role of DNA methylation in head and neck cancer , 2011, Clinical Epigenetics.
[25] A. Bartoszek,et al. DNA methylation in cancer development, diagnosis and therapy--multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. , 2011, Mutagenesis.
[26] Takuji Tanaka,et al. Understanding Carcinogenesis for Fighting Oral Cancer , 2011, Journal of oncology.
[27] Felix Krueger,et al. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..
[28] Yuwei Wu,et al. Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis. , 2010, American journal of clinical pathology.
[29] N. Geacintov,et al. Impact of carcinogen-DNA adducts on DNA methylation , 2010 .
[30] Chih-Yi Chen,et al. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. , 2010, The Journal of clinical investigation.
[31] W. Westra,et al. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. , 2009, Annual review of pathology.
[32] M. George,et al. Mutations induced by benzo[a]pyrene and dibenzo[a,l]pyrene in lacI transgenic B6C3F1 mouse lung result from stable DNA adducts. , 2008, Mutagenesis.
[33] C. Harris,et al. Advances in chemical carcinogenesis: a historical review and prospective. , 2008, Cancer research.
[34] T. Mikkelsen,et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.
[35] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[36] M. Katoh,et al. WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.
[37] W. Lam,et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.
[38] C. Scully,et al. Tobacco, oral cancer, and treatment of dependence. , 2005, Oral oncology.
[39] S. Cutts,et al. Cytosine Methylation Enhances Mitoxantrone-DNA Adduct Formation at CpG Dinucleotides* , 2001, The Journal of Biological Chemistry.
[40] D. Weisenberger,et al. Cytosine Methylation in a CpG Sequence Leads to Enhanced Reactivity with Benzo[a]pyrene Diol Epoxide That Correlates with a Conformational Change* , 1999, The Journal of Biological Chemistry.
[41] J. T. Wachsman,et al. DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. , 1997, Mutation research.
[42] S. Gollin,et al. Visualization of INT2 and HST1 Amplification in oral squamous cell carcinomas , 1995, Genes, chromosomes & cancer.
[43] K. Somers,et al. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.
[44] M. Wojciechowski,et al. Inhibition of DNA methyltransferases in vitro by benzo[a]pyrene diol epoxide-modified substrates. , 1984, The Journal of biological chemistry.
[45] Peter A. Jones,et al. Inhibition of DNA methylation by chemical carcinogens in vitro , 1983, Cell.
[46] Michael R Hamblin,et al. CA : A Cancer Journal for Clinicians , 2011 .
[47] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[48] A. Feinberg,et al. The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.
[49] F Kalberlah,et al. Cancer risk assessment for oral exposure to PAH mixtures , 2002, Journal of applied toxicology : JAT.
[50] K. Robertson,et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.